Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma
Ji Liu,1 Zhekang Liu,2 Deming Xu,1 Tao Zhou,1 Ang Li,1 Jiali Hu,1 Hong Li,3 Wenjie Li,1 Zengqing Wang,1 Zhiping Yu,1 Linxiang Zeng1 1Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People’s Republic of China; 2R...
Saved in:
| Main Authors: | Liu J, Liu Z, Xu D, Zhou T, Li A, Hu J, Li H, Li W, Wang Z, Yu Z, Zeng L |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/pretreatment-lipoproteina-as-a-biomarker-for-egfr-mutation-and-prognos-peer-reviewed-fulltext-article-IJGM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Robust prognostic biomarkers and a risk prediction model specific to EGFR-mutated lung adenocarcinoma patients via multicohort meta-analysis
by: Haangik Park, et al.
Published: (2025-03-01) -
Epidermal growth factor receptor mutation in adenocarcinoma lung in a North Indian population: Prevalence and relation with different clinical variables
by: Basharat Ahmad Kasana, et al.
Published: (2016-01-01) -
Integrated Bioinformatics Analysis and Cellular Experimental Validation Identify Lipoprotein Lipase Gene as a Novel Biomarker for Tumorigenesis and Prognosis in Lung Adenocarcinoma
by: Wanwan He, et al.
Published: (2025-05-01) -
The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
by: Elisna Syahruddin, et al.
Published: (2025-01-01) -
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation
by: Jiahui Dong, et al.
Published: (2025-07-01)